• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, October 26, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

AI identifies mesothelioma cells by scattered-light spectra

by
October 26, 2026
in Cancer
Reading Time: 3 mins read
0
AI identifies mesothelioma cells by scattered-light spectra

AI identifies mesothelioma cells by scattered-light spectra

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A machine learning system identified cancerous mesothelioma cells from reactive mesothelial cells with about 91% accuracy in patient-based validation by analyzing how the cells scatter white light. The peer-reviewed experimental study, led by Assistant Professor Yuka Tsuri at Nara Institute of Science and Technology and published in Scientific Reports on August 3, 2026, demonstrates a proof-of-concept approach for augmenting cytology with optical measurements. It does not establish performance in routine clinical diagnosis, and the authors describe the additional cancer-cell applications as showing potential rather than a uniform diagnostic result.

Cytology tests examine cells collected from bodily fluids for signs of malignancy, including enlarged nuclei and abnormal cell shapes. Pathologists interpret stained samples using microscopes, and the outcome can depend on the skill of the person performing the assessment. In some cases, cancerous and normal cells can appear identical under conventional microscopy even though differences exist at scales smaller than those microscopes resolve. Such changes may involve nanometric structures, including actin filaments and microtubules that form the internal cellular scaffolding, potentially altering how a cell scatters light.

For the main experiment, researchers examined cytology specimens containing mesothelioma cells and reactive mesothelial cells, which can have very similar appearances. They used dark-field microscopy, a technique that captures light scattered by an object rather than light absorbed while passing through it. White light with wavelengths between 420 and 720 nanometers was used to illuminate the specimens, and the researchers recorded the resulting scattered-light spectra. The spectral data were first condensed with principal component analysis and then passed to a support vector machine classifier that distinguished between the cell types. In patient-based validation after training, the pipeline separated mesothelioma cells from reactive mesothelial cells with approximately 91% accuracy.

The system also showed potential for distinguishing gastric and urothelial cancer cells and several types of lung and thoracic cancer, although its performance varied with tumor type and validation approach. Those exploratory results should not be read as evidence of the same performance across all cancers or as proof that the method improves diagnoses in routine practice. The researchers’ interpretation was that light-scattering spectra contain information at the submicron scale and can be sensitive to differences between cell types. The experiment therefore supports the technical feasibility of combining dark-field spectroscopy, dimensionality reduction and machine learning in a cytology workflow.

Assistant Professor Tsuri said that integrating the spectroscopic system with a microscope could serve as an aid to pathologists and potentially improve diagnostic accuracy. The team presented the approach as a complement to pathologists’ skill and judgment rather than a replacement for them. Researchers are working to optimize the optical settings and operating protocol and are applying more advanced machine-learning methods to improve diagnostic accuracy further. The present study remains an experimental proof of concept: the reported 91% result concerns mesothelioma versus reactive mesothelial cells in patient-based validation, while performance in other tumor groups was variable. Its broader significance lies in showing that subtle differences in cellular light scattering can be converted into spectral features for computational classification, providing a basis for subsequent evaluation of the method.

Subject of Research: Machine learning analysis of white-light scattering spectra for identifying cancerous cells in cytology specimens

Article Title: A machine learning system that identifies cancer cells based on how they scatter light

Article References: A machine learning system that identifies cancer cells based on how they scatter light. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: machine learning, cancer identification, cytology, dark-field microscopy, light scattering, mesothelioma, spectroscopy, principal component analysis, support vector machine, pathology, machine, learning

News Source: Nathaniel Bowman. (October 26, 2026). AI identifies mesothelioma cells by scattered-light spectra. Scienmag.

Tags: cancer identificationcytologydark-field microscopylearninglight scatteringmachineMachine Learningmesotheliomapathologyprincipal component analysisspectroscopysupport vector machine
Share12Tweet7Share2ShareShareShare1

Related Posts

Structured exercise associated with improved survival in cancer meta-analysis

Structured exercise associated with improved survival in cancer meta-analysis

October 26, 2026
Bayesian reanalysis supports rituximab–lenalidomide non-inferiority in follicular lymphoma

Bayesian reanalysis supports rituximab–lenalidomide non-inferiority in follicular lymphoma

October 26, 2026

Insurance expansion shortened time to BRCA testing and facilitated preventive strategies: a single-center cohort study in Japan

October 26, 2026

International observational study tests PANXEON for early pancreatic cancer

October 26, 2026

POPULAR NEWS

  • Structured exercise associated with improved survival in cancer meta-analysis

    Structured exercise associated with improved survival in cancer meta-analysis

    29 shares
    Share 12 Tweet 7
  • Bayesian reanalysis supports rituximab–lenalidomide non-inferiority in follicular lymphoma

    29 shares
    Share 12 Tweet 7
  • Insurance expansion shortened time to BRCA testing and facilitated preventive strategies: a single-center cohort study in Japan

    29 shares
    Share 12 Tweet 7
  • BMJ commentary links green transition revenue to universal health coverage

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Structured exercise associated with improved survival in cancer meta-analysis

Bayesian reanalysis supports rituximab–lenalidomide non-inferiority in follicular lymphoma

Insurance expansion shortened time to BRCA testing and facilitated preventive strategies: a single-center cohort study in Japan

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.